Calumet Inc

CLMT remains in a Stage 2 advancing uptrend with steep parabolic acceleration riding the 9 EMA and extreme overbought conditions across RSI, Options Score, and NTM P/E signaling short-term exhaustion risk. Medium-term continuation structure remains intact under rising EMAs, but distribution vulnerability is elevated. Execution is deferred until a corrective pullback into the confluence of the 9, 21, and 50 EMAs or a prior resistance-turned-support zone to improve risk–reward. Key risks include a rapid snap-back bypassing dynamic EMA support and a decisive close below the 21 EMA invalidating the bullish setup.

• ↑Plans to scale SAF capacity to 150M gallons, a 4–5x volume increase
• ↑Q1 adjusted EBITDA of $50.1M with $60M in YTD operational savings
• ↓Negative earnings yield indicates revenue and margin compression risk